| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/12/2012 | US20120011621 MEG1 Endosperm-Specific Promoters and Genes |
| 01/12/2012 | US20120011619 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/12/2012 | US20120011617 Regulatory Elements Associated with CBF Transcription Factors of Maize |
| 01/12/2012 | US20120011616 Modification of Plant Development and Morphology |
| 01/12/2012 | US20120011614 Dominant Gene Suppression Transgenes and Methods of Using Same |
| 01/12/2012 | US20120011610 Soybean variety a1023484 |
| 01/12/2012 | US20120011609 Soybean variety a1023199 |
| 01/12/2012 | US20120011608 Soybean variety a1023171 |
| 01/12/2012 | US20120011607 Soybean variety a1023169 |
| 01/12/2012 | US20120011606 Soybean variety a1022841 |
| 01/12/2012 | US20120011605 Soybean variety a1022840 |
| 01/12/2012 | US20120011604 Soybean variety a1020078 |
| 01/12/2012 | US20120011603 Soybean variety a1019993 |
| 01/12/2012 | US20120011602 Soybean variety a1016011 |
| 01/12/2012 | US20120011601 Soybean variety a1015895 |
| 01/12/2012 | US20120011600 Optimizing glycan processing in plants |
| 01/12/2012 | US20120011598 Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics |
| 01/12/2012 | US20120011597 Certain human genomic dna associated with total red-green colorblindness |
| 01/12/2012 | US20120010725 Tissue Implants for Implantation and Methods for Preparing the Same |
| 01/12/2012 | US20120010387 Antibody variants composition |
| 01/12/2012 | US20120010384 Epitope synchronization in antigen presenting cells |
| 01/12/2012 | US20120010278 Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections |
| 01/12/2012 | US20120010276 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 01/12/2012 | US20120010275 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 |
| 01/12/2012 | US20120010273 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 01/12/2012 | US20120010271 Single-stranded nucleic acid molecule for controlling gene expression |
| 01/12/2012 | US20120010270 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 6 (TSSC6) |
| 01/12/2012 | US20120010269 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN SMS3 |
| 01/12/2012 | US20120010268 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN ACHAETE-SCUTE HOMOLOG 2 (HASH2) |
| 01/12/2012 | US20120010178 Methods and compounds for treatment of neurodegenerative disorders |
| 01/12/2012 | US20120010177 MicroRNA Modulators and Method for Identifying And Using The Same |
| 01/12/2012 | US20120010176 Utrophin promoter activity upregulation for the treatment of muscular dystrophy |
| 01/12/2012 | US20120010156 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/12/2012 | US20120010155 Gntiii expression in plants |
| 01/12/2012 | US20120010152 Targeting of Podoplanin with Lectin for Use in the Prevention and Treatment of Cancer |
| 01/12/2012 | US20120010138 Novel uses of vegfxxxb |
| 01/12/2012 | US20120010137 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer |
| 01/12/2012 | US20120010131 Novel cyclosporin analogues |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120010100 Plant farnesyltransferases |
| 01/12/2012 | US20120010092 Methods for Identifying Fragile Histidine Triad (FHIT) Interaction and Uses Thereof |
| 01/12/2012 | US20120009682 Method for selecting a high expression recombinant cell line |
| 01/12/2012 | US20120009681 Platform of dendritic cell (dc)-based vaccination |
| 01/12/2012 | US20120009680 Cancerous Disease Modifying Antibodies |
| 01/12/2012 | US20120009679 Tissue Implants for Implantation and Methods for Preparing the Same |
| 01/12/2012 | US20120009678 Immunotherapy targeting intracellular pathogens |
| 01/12/2012 | US20120009677 Method for producing a bio-artificial transplant |
| 01/12/2012 | US20120009676 Generation of induced pluripotent stem cells from small volumes of peripheral blood |
| 01/12/2012 | US20120009675 Methods of producing pancreatic hormones |
| 01/12/2012 | US20120009674 Use of a GSK-3 Inhibitor to Maintain Potency of Cultured Cells |
| 01/12/2012 | US20120009673 Mesenchymal stem cells for the treatment of cns diseases |
| 01/12/2012 | US20120009672 Methods for Differentiating Cells into Hepatic Stellate Cells and Hepatic Sinusoidal Endothelial Cells, Cells Produced by the Methods, and Methods for Using the Cells |
| 01/12/2012 | US20120009671 System and method for microfluidic cell culture |
| 01/12/2012 | US20120009670 Use of Molecular Chaperones for the Enhanced Production of Secreted, Recombinant Proteins in Mammalian Cells |
| 01/12/2012 | US20120009669 Bifunctional compound with monosaccharide and n2s2 ligand, and preparation and use thereof |
| 01/12/2012 | US20120009653 Highly stable beta-class carbonic anhydrases useful in carbon capture systems |
| 01/12/2012 | US20120009652 Highly stable beta-class carbonic anhydrases useful in carbon capture systems |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009647 Thermostable luciferases and methods of production |
| 01/12/2012 | US20120009645 Culture of pluripotent and multipotent cells on microcarriers |
| 01/12/2012 | US20120009644 Tissue Implants for Implantation and Methods for Preparing the Same |
| 01/12/2012 | US20120009633 Nitrilases and methods for making and using them |
| 01/12/2012 | US20120009623 Methods for Recombinant Manufacturing of Anti-RSV Antibodies |
| 01/12/2012 | US20120009621 Novel antibody and antibody fragment introduced new modification sites |
| 01/12/2012 | US20120009618 Endothelial cell production by programming |
| 01/12/2012 | US20120009601 Methods and compositions for reprogramming cells |
| 01/12/2012 | US20120009598 T2r, a novel family of taste receptors |
| 01/12/2012 | US20120009594 Method for measuring beta-glucan, and beta-glucan-binding protein for use in the method |
| 01/12/2012 | US20120009590 Device and non-toxic compositions and methods for permeabilization of drosophila embryos |
| 01/12/2012 | US20120009579 Monocyte-derived nucleic acids and related compositions and methods |
| 01/12/2012 | US20120009578 Microvesicle-Based Compositions and Methods |
| 01/12/2012 | US20120009561 Methods of evaluating a test agent in a diseased cell model |
| 01/12/2012 | US20120009559 Automated cell culture system and process |
| 01/12/2012 | US20120009324 Recombinant polypeptide having pancreatic lipase activity and nucleic acid coding sequence thereof, and their production and use |
| 01/12/2012 | US20120009300 Family gh 61 polypeptides |
| 01/12/2012 | US20120009271 Method of disease-induced and receptor-mediated stem cell neuroprotection |
| 01/12/2012 | US20120009270 Treatment methods using a particulate cartilage system |
| 01/12/2012 | US20120009244 NEUROD1 GENE EXPRESSION IN NON-ENDOCRINE PANCREATIC EPITHELIAL CELLS (NEPECs) |
| 01/12/2012 | US20120009224 Particulate cartilage treatment composition |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009208 USE OF MEMBRANE ATTACK COMPLEX (MAC) AND IMMUNE COMPLEXES (ICs) TO ACTIVATE T-CELLS AND THE GENERATION OF REGULATORY T CELLS |
| 01/12/2012 | US20120009205 Modified Fc Molecules |
| 01/12/2012 | US20120009202 Target host factors for treating viral infection |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009194 Antibodies to endoplasmin and their use |
| 01/12/2012 | US20120009193 Method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same |
| 01/12/2012 | US20120009192 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof |
| 01/12/2012 | US20120009181 Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof |
| 01/12/2012 | US20120009166 Isolated monocyte populations and related therapeutic applications |
| 01/12/2012 | US20120009162 T cell receptor and nucleic acid encoding the receptor |
| 01/12/2012 | US20120009161 Therapeutic retroviral vectors for gene therapy |
| 01/12/2012 | US20120009160 Cells for the treatment of nervous system disorders |
| 01/12/2012 | US20120009158 VENTRICULAR INDUCED PLURIPOTENT STEM (ViPS) CELLS FOR GENERATION OF AUTOLOGOUS VENTRICULAR CARDIOMYOCYTES AND USES THEREOF |
| 01/12/2012 | US20120009157 Culture method of embryoid bodies and/or neural stem cells derived from human differentiated cell-derived pluripotent stem cells |
| 01/12/2012 | US20120009153 Compositions for bacterial mediated gene silencing and methods of using the same |
| 01/12/2012 | US20120009152 Nitric oxide donors for treatment of disease and injury |
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |